Canadian Cardiovascular Society sets new guidelines for management of lipid metabolism disorders that affect cholesterol and cause atherosclerosis

October 11, 2016

Philadelphia, PA, October 11, 2016 - The Canadian Cardiovascular Society (CCS) has published an important update to its guidelines for the management of dyslipidemia - lipid metabolism disorders - that can cause cardiovascular disease. These disorders are very common, affect atherosclerosis-promoting lipids like cholesterol, and are a major target of widely used drugs like statins. The guidelines update evidence-based guidance for cardiologists and other clinicians regarding which patients will benefit from statin therapy. There is also new information on the use of health behavior modifications and non-statin medications to help doctors make the difficult decisions about when to use drugs to treat cholesterol and when other approaches are possible. The update is published in the Canadian Journal of Cardiology.

Central to the new guidelines is the recommendation that decision-making should be shared between physician and patient. "As dyslipidemia is an important risk factor for cardiovascular disease, these guidelines will allow appropriate risk assessment, treatment, and surveillance options of our at-risk population," explained Todd J. Anderson, MD, of the Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary. "The overall goal of the process was to produce a document based on the best available evidence that would allow clinicians and patients to make collaborative treatment decisions. These guidelines are not absolute, but are meant to launch one-on-one discussion between practitioner and patient."

The revised guidelines reflect new clinical trial and epidemiologic evidence. They include important recommendations like: The panel has strengthened its previous lifestyle advice. "Lifestyle interventions remain the cornerstone of chronic disease prevention, including cardiovascular disease," emphasized Dr. Anderson. "Data from the INTERHEART study indicate that, in addition to the traditional risk factors (abnormal lipids, hypertension, smoking, and diabetes), abdominal obesity, dietary patterns, alcohol consumption, physical inactivity, and psychosocial factors are modifiable risk factors for heart attacks worldwide in both sexes and at all ages."

Specifically, the panel recommends that: ###

Elsevier Health Sciences

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to